Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Morphic Holding (MORF – Research Report), GoDaddy (GDDY – Research Report) and Veeva Systems (VEEV – Research Report).
Morphic Holding (MORF)
In a report issued on November 3, Gregory Renza from RBC Capital maintained a Buy rating on Morphic Holding, with a price target of $76.00. The company’s shares closed last Friday at $22.57, close to its 52-week low of $19.35.
According to TipRanks.com, Renza is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Morphic Holding with a $60.60 average price target, which is a 187.2% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock.
See today’s best-performing stocks on TipRanks >>
GoDaddy (GDDY)
RBC Capital analyst Brad Erickson maintained a Hold rating on GoDaddy on November 3 and set a price target of $90.00. The company’s shares closed last Friday at $85.56, close to its 52-week high of $85.78.
According to TipRanks.com, Erickson is a 5-star analyst with an average return of
GoDaddy has an analyst consensus of Moderate Buy, with a price target consensus of $93.56, implying a 20.1% upside from current levels. In a report issued on November 3, UBS also maintained a Hold rating on the stock with a $85.00 price target.
Veeva Systems (VEEV)
Wells Fargo analyst Stan Berenshteyn maintained a Buy rating on Veeva Systems today and set a price target of $229.00. The company’s shares closed last Friday at $194.59.
According to TipRanks.com, Berenshteyn is a 1-star analyst with an average return of
Veeva Systems has an analyst consensus of Moderate Buy, with a price target consensus of $225.94.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MORF:
- Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
- Morphic expects cash to fund operations through second half of 2027
- Morphic reports Q3 EPS (73c), consensus (95c)
- Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
- Biotech Alert: Searches spiking for these stocks today
